TMEM106A mediates atherosclerosis progression through macrophage-centered immune responses and chemokine signaling
BackgroundAtherosclerosis (AS) remains a leading cause of cardiovascular morbidity and mortality, characterized by intricate interactions between immune dysregulation and lipid metabolism abnormalities—identifying key mediators in its pathogenesis is c…